IP Library Granted Patent US 12,622,576
Granted Patent B2
US 12,622,576 · App. 17/814,385 · Granted May 12, 2026

Device and method for applying a pharmaceutical fluid

Inventors: Sebastian Vogt (Wehrheim, DE); Thomas Kluge (Wehrheim, DE)
Assignee: Heraeus Medical GmbH
A61B1/015A61B1/018A61B2017/044A61B17/3472A61B2017/561A61B17/68A61B17/7098A61B17/8057A61B17/8605A61B2017/8655A61B17/8805A61B17/8811A61F2/28A61F2002/30143A61M5/14276A61M2005/3128A61M25/007A61M2039/025A61M39/22A61M2039/2426A61M2039/2433A61M2039/2473A61M2039/2493A61M2210/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,622,576
App. No.
17/814,385
Granted
May 12, 2026
Kind
B2
Abstract

A device and method for applying a pharmaceutical fluid comprising a hollow cylindrical body, which surrounds a channel that extends through the body from a proximal body end to a distal body end of the body, wherein an outer surface of the body has at least partially an external thread, and has a connecting element arranged at the proximal body end, via which a proximal channel end of the channel can be reversibly connected in terms of fluid conduction to a reservoir for the pharmaceutical fluid.

Claims (26)

1 . A device for applying a pharmaceutical fluid comprising:

a hollow cylindrical body, which surrounds a channel that extends through the body from a proximal body end to a distal body end of the body,

wherein an outer surface of the body has at least partially an external thread, and comprising a connecting element arranged at the proximal body end, via which a proximal channel end of the channel can be reversibly connected in terms of fluid conduction to a reservoir for the pharmaceutical fluid,

wherein a check valve that is arranged in the channel and is fluid-impermeable in a direction of the proximal channel end, and a sealing element arranged in the channel distal to the check valve, which closes a distal channel end of the channel in terms of fluid conduction and which has a gap that can be reversibly opened in terms of fluid conduction when pressure is applied to the pharmaceutical fluid from the direction of the proximal channel end, such that the pharmaceutical fluid can be applied from the distal channel end.

2 . The device according to claim 1 , wherein the gap reversibly opens in terms of fluid conduction upon the application of pressure greater than 5 N/cm 2 .

3 . The device according to claim 1 , wherein the check valve is a ball check valve comprising a ball and a restoring element.

4 . The device according to claim 3 , wherein the restoring element and the sealing element are configured in one piece.

5 . The device according to claim 1 , wherein a filter element is arranged in the channel.

6 . The device according to claim 5 , wherein the filter element is arranged in the channel proximally to the check valve.

7 . The device according to claim 5 , wherein the filter element is a microporous filter plate.

8 . The device according to claim 7 , wherein the microporous filter plate has pores with an average pore diameter of less than 40 μm.

9 . The device according to claim 1 , wherein a hollow cylindrical sleeve is arranged in the channel distally to the sealing element, in order to prevent the discharging of the sealing element from the distal channel end during the application of the pharmaceutical fluid.

10 . The device according to claim 1 , wherein the proximal channel end is designed to be polygonal, and the connecting element is equipped with a polygonal connecting element section, in order to reversibly connect in terms of fluid conduction the connecting element to the proximal channel end by inserting the connecting element section into the proximal channel end.

11 . The device according to claim 10 , wherein the proximal channel end has a larger axial extension than the connecting element section, such that, after removal of a part of the proximal channel end, the connecting element can be reversibly connected in terms of fluid conduction to a part of the proximal channel end remaining on the device by inserting the connecting element section into the remaining proximal channel end.

12 . The device according to claim 1 , wherein the body comprises a metal and/or a polymer.

13 . A method for applying a pharmaceutical fluid by means of a device, said device comprising:

a hollow cylindrical body, which surrounds a channel that extends through the body from a proximal body end to a distal body end of the body,

wherein an outer surface of the body has at least partially an external thread, and comprising a connecting element arranged at the proximal body end, via which a proximal channel end of the channel can be reversibly connected in terms of fluid conduction to a reservoir for the pharmaceutical fluid,

wherein a check valve that is arranged in the channel and is fluid-impermeable in a direction of the proximal channel end, and a sealing element arranged in the channel distal to the check valve, which closes a distal channel end of the channel in terms of fluid conduction and which has a gap that can be reversibly opened in terms of fluid conduction when pressure is applied to the pharmaceutical fluid from the direction of the proximal channel end, such that the pharmaceutical fluid can be applied from the distal channel end;

said method for applying the pharmaceutical fluid by means of the device, comprising the following steps:

a. Implanting of the device;

b. Connecting in terms of fluid conduction of the device to a reservoir for the pharmaceutical fluid;

c. Building up of a conveyance pressure on the pharmaceutical fluid from the direction of the proximal channel end of greater than 5 N/cm 2 ;

d. Opening in terms of fluid conduction of the gap in the sealing element by the action of the conveyance pressure;

e. Dispensing of the pharmaceutical fluid from the gap that is open in terms of fluid conduction;

f. Closing in terms of fluid conduction of the gap by reducing the conveyance pressure to 5 N/cm 2 or less.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 22, 2022
From: VOGT, SEBASTIAN; KLUGE, THOMAS
To: HERAEUS MEDICAL GMBH
Reel/Frame 060596/0743 →
Priority Claims (1)
EP 21188130 · Jul 28, 2021 · regional
Continuity (1)
Related Publication 20230033990A1 · Feb 2, 2023
References Cited (35)
US 4413985A · Wellner · 1983 [cited by examiner]
US 5478216A · Neward · 1995 [cited by examiner]
US 5571139A · Jenkins, Jr. · 1996 [cited by examiner]
US 7175626B2 · Neff · 2007 [cited by examiner]
US 7717947B1 · Wilberg · 2010 [cited by examiner]
US 9616205B2 · Nebosky et al. · 2017 [cited by applicant]
US 10357298B2 · Nebosky et al. · 2019 [cited by applicant]
US 20040215155A1 · Wolfe · 2004 [cited by examiner]
US 20050015059A1 · Sweeney · 2005 [cited by examiner]
US 20060089647A1 · Culbert · 2006 [cited by examiner]
US 20070233071A1 · Dewey · 2007 [cited by examiner]
US 20080039846A1 · Lee · 2008 [cited by examiner]
US 20100030135A1 · Mitchell · 2010 [cited by examiner]
US 20100042215A1 · Stalcup · 2010 [cited by examiner]
US 20110060373A1 · Russell · 2011 [cited by examiner]
US 20120316571A1 · Sharkey · 2012 [cited by examiner]
US 20130096634A1 · Suh · 2013 [cited by examiner]
US 20130144344A1 · Giancola · 2013 [cited by examiner]
US 20130184619A1 · Von Hollen · 2013 [cited by examiner]
US 20140276347A1 · Stone · 2014 [cited by examiner]
US 20150065992A1 · Korkuch · 2015 [cited by examiner]
US 20150080794A1 · Duong · 2015 [cited by examiner]
US 20150080813A1 · Crawford et al. · 2015 [cited by applicant]
US 20150122369A1 · Py · 2015 [cited by examiner]
US 20180014867A1 · Mazel · 2018 [cited by applicant]
US 20180239370A1 · Perry, Jr. · 2018 [cited by examiner]
US 20190167326A1 · Greenhalgh · 2019 [cited by examiner]
US 20220134077A1 · Drew · 2022 [cited by examiner]
US 20220160965A1 · Kim · 2022 [cited by examiner]
BR MU9100119U2 · 2012 [cited by applicant]
DE 3508759A1 · 1985 [cited by applicant]
DE 19949285C2 · 2002 [cited by applicant]
DE 102011112890B4 · 2019 [cited by applicant]
EP 1210019B2 · 2009 [cited by applicant]
EP 2887899B1 · 2017 [cited by applicant]